MedPath

Magnetic Resonance Elastography of Cardiac Transplant Rejection

Not Applicable
Terminated
Conditions
Acute Graft Rejection
Interventions
Device: Magnetic Resonance Elastography driver
Registration Number
NCT02266914
Lead Sponsor
Ohio State University
Brief Summary

Magnetic Resonance Elastography (MRE) for cardiac transplant patients.

Detailed Description

Patient will undergo MRE beginning 4-8 weeks post transplant, then with each scheduled cardiac biopsy through 7-8 months post transplant. Results of the MRE will be compared against results of the cardiac biopsy to determine if the non-invasive MRE can predict cardiac transplant rejection.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Patients must have undergone cardiac transplantation at the Ohio State University Ross Heart Hospital.
  • Patients must be able to lie flat on their back in the scanner for up to 60 minutes
  • Patient must be able to hold their breath for up to 15 seconds at a time.
Exclusion Criteria
  • Patients who are claustrophobic
  • Patients who are pregnant, due to potential risks to the fetus.
  • Patients with any unapproved, non-MRI safe metal/devices in their bodies.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Arm 1Magnetic Resonance Elastography driverPatients who have received a cardiac transplant at The Ohio State University Ross Heart Hospital will undergo Magnetic Resonance Elastography (MRE) (using a Magnetic Resonance Elastography driver) within 24-48 hours of standard of care biopsy. Results of both will be compared to determine if MRE can successfully predict cardiac transplant rejection.
Primary Outcome Measures
NameTimeMethod
Cardiac Stiffness With Magnetic Resonance Elastography (MRE)24-48 hours

MRE scans will be performed within 24-48 hours of standard of care cardiac biopsies for patients who have undergone cardiac transplant at The Ohio State University Ross Heart Hospital. Stiffness results from the MRE will be compared to histopathology from the cardiac biopsy to determine if the completely non-invasive MRE can successfully predict transplant rejection.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Ohio State University Medical Center

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath